After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Vertex Minerals has initiated the commissioning of a newly installed ore sorter/pre-concentrator at its Hill End Gold plant ...

Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...

That’s the opinion of top Vertex Pharmaceuticals executives and several market analysts about the Boston-based company’s painkiller Journavx, which the Food and Drug Administration approved on ...

Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 9% from a peak the stock set in November, despite some highly positive news. The U.S. Food and Drug Administration (FDA) approved ...

(Reuters) -The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals (NASDAQ: VRTX )' drug to treat acute ...

Google has released a whole new range of AI-powered research and interactions that simply can't be matched by DeepSeek or OpenAI.

A novel Vertex Pharmaceuticals drug that takes a new approach to pain is now approved by the FDA, a landmark decision for a first-in-class product that brings patients a treatment alternative ...

Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.

Vertex Pharmaceuticals (VRTX – Research Report) received a Buy rating and a $480.00 price target from Cantor Fitzgerald analyst Olivia Brayer yesterday. The company’s shares closed yesterday ...

To define a modern curve for normal labor, these researchers evaluated data on 1329 nulliparous, full-term women with spontaneous labors and vertex presentations who gave birth to singletons of ...